Author Profile

Written By

Jeffrey Smoot

Information Scientist, CAS

Jeffrey Smoot has been an information scientist at CAS for 30 years. Prior to joining CAS, Jeffrey held a research position with Northwestern University and was a Hematology-Oncology Fellow at The Ohio State University. He obtained a B.A. in chemistry and a B.S. in biology from the University of California, Irvine and a PhD. in Biochemistry from The Ohio State University.

Latest Content from Jeffrey Smoot

COVID Omicron variant illustration

November 30, 2021

Omicron variant accelerates need for more diverse COVID-19 vaccine strategy

Current vaccines against SARS-CoV-2 that target the spike protein are an important step toward developing antiviral therapeutics and next-generation vaccines. These vaccines have reduced hospitalizations and deaths. However, as the virus continues to mutate and evolve, solely targeting the spike protein may not be enough for protective immunity.

October 29, 2020

Building on “flu shot” success to tackle COVID-19

June 11, 2020

Classic and new technologies vying to be the first COVID-19 vaccine

Development of a COVID-19 vaccine remains a challenge. This article will review general vaccine approaches, and provide insight into the current COVID-19 vaccine pipeline.